CGCSA Legal & Regulatory Affairs 1 PRESENTATION BY CONSUMER GOODS COUNCIL OF SOUTH AFRICA ON: Proposed Medicines and Related Substances Amendment Bill.

Slides:



Advertisements
Similar presentations
Transparency and Domestic Regulation Mina Mashayekhi Division on International Trade UNCTAD.
Advertisements

Division: EIDD WTO TBT Workshop on Good Regulatory Practice March 2008 Focus on Transparency and Consultation.
Session 6 : Need for good governance Importance of veterinary legislation and its appropriate implementation Jean-Luc ANGOT, CVO, France 14 March 2013.
WHO FOOD LAW COURSE FOOD LABELLING AND PUBLIC HEALTH.
ROLE OF STANDARDS IN FOOD SAFETY Dr. R. K. Bajaj Bureau of Indian Standards.
Presentation to the Joint Committees’ Meeting on Second 2010 FIFA World Cup South Africa Special Measures Bill (proposed section 76 B ) and 2010.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
1 MANUFACTURING AND PRODUCTION OF BIOLOGICAL PRODUCTS (ERT 455) HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM Munira Mohamed Nazari School.
POULTRY BRINE INJECTION DAFF AND DTI PRESENTATION Dr. NTSHABELE DIRECTOR: FOOD SAFETY AND QUALITY ASSURANCE PORTFOLIO COMMITTEE ON AGRICULTURE, FORESTRY.
Enforcement in the Pharmaceutical Industry Michael K. Loucks First Assistant U.S. Attorney United States Attorney’s Office District of Massachusetts October.
1 Certification Chapter 14, Storey. 2 Topics  What is certification?  Various forms of certification  The process of system certification (the planning.
Joint Submission: South African National Blood Service (SANBS) & Natal Bioproducts Institute (NBI): National Health Bill (B32 of 2003) 19 August 2003 Cape.
“Empowering doctors to bring health to the nation” COMMENTS BY THE SOUTH AFRICAN MEDICAL ASSOCIATION (SAMA) on THE MEDICINES AND RELATED SUBSTANCES AMENDMENT.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
SAFETY OF GENETICALLY MODIFIED FOODS E Jane Morris.
Massmart Presentation on Medicines and Related Substances Amendment Bill, 2008 Presentation by Graham Rebello Massmart Channel Executive.
GENETICALLY MODIFIED ORGANISM PRESENTATION 13 September 2013 By Department of Trade and Industry.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
Prepared by: Taruna Navraksha Irfaan Shashi Food Quality & Certification.
Oral Submission on the Tobacco Products Control Amendment Bill, 2008 to the Parliamentary Portfolio Committee on Health JT International South Africa (Pty)
DEPARTMENT OF AGRICULTURE PRESENTATION TO PARLIAMENTARY PORTFOLIO COMMITTEE ON AGRICULTURE AND LAND AFFAIRS ON VETERINARY PHARMACEUTICALS 19 SEPTEMBER.
Competition Amendment Bill PASA Presentation by Pierre Coetzee 29 July 2008.
EU Food/Feed Safety Rules Industry Information Session June 16, 2005 Presented by AAFC.
Joint comment by The Nutrition Society of South Africa Association for Dietetics in South Africa Presented by Prof Johann Jerling Medicines and Related.
The perspective of the food and drink manufacturing sector Meeting consumer needs Responding to new challenges Dominique TAEYMANS Director Scientific &
Safety and Labelling Aspects of GM Foods Presentation to the Portfolio Committee on Environmental Affairs and Tourism By The National Department of Health.
Canadian Food Safety Standards May 2008 Austin, Texas.
Parliamentary Portfolio Committee on Health Medicines and Related Substances Amendment Bill Comment by Danone Clover (Pty) Ltd Presented by Jane Badham,
Briefing by Department of Health to joint meeting of the Portfolio Committees on Agriculture, Forestry and Fisheries, Health, Trade and Industry, Rural.
THE ALLIED HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA (AHPCSA) MEDICINES AND RELATED SUBSTANCES ACT (101/1965) AMENDMENT BILL (B6-2014) PRESENTATION BY.
Presented by J F Luterek, Pr.Eng Hahn & Hahn Attorneys
Environmental Management System Definitions
The Consumer Protection Bill Presentation to the Portfolio Committee on Trade and Industry 3 September 2008 Ref No
1 1 © F-D & B, 2002 BALKAN LEGAL FORUM 2002 SOFIA, BULGARIA Dr. Jürgen Brandstätter ADVERTISING ACTIVITIES IN THE LIGHT OF EUROPEAN LAW STANDARDS.
General overview of South Africa’s commitment to global market access & maintenance based on requirements for phytosanitary measures by PATRICK TSHIKHUDO.
Special Railways Phase III Proposed approach to regulatory changes Jakarta 16 May 2011.
Making false claims about medicines - selling, advertising Enforcing the law Fatima Hassan Senior Attorney 26 September 2006.
DISCOVERY HEALTH COMMENTS ON THE MEDICINES AND RELATED SUBSTANCES BILL August 2008.
IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.
Comments on the Report of the Gambling Review Commission 9 November 2011 By Pierre Coetzee Payments Association Of South Africa 1 Staying relevant, aligning.
Portfolio Committee for Health Medicines and Related Substances Amendment Bill (06/08/08) IMSA represents Research Based Pharmaceutical Companies.
Waste Management Amendment Bill B Submission by Business Unity South Africa January 2014.
PRESENTATION TO THE PORTFOLIO COMMITTEE ON TRADE AND INDUSTRY COMPANIES BILL [B ] 13 August 2008 By: Bernard Peter Agulhas – Acting Chief Executive.
WHO FOOD LAW COURSE INTRODUCTION NED KINGCOTT. SCOPE OF FOOD LAW  Food standards (eg meat content)  Additives and contaminants  Hygiene: animal and.
DOCUMENTATION ISO/IEC 17025:2005 Documentation.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
Directive 2009/39/EC on PARNUTS Directive 96/8/EC on Foods for use in energy- restricted diets for weight reduction Martijn Martena, PhD Netherlands Food.
Presentation for Visiting Delegation from Colombia December 1, 2015 Melissa San Miguel Grocery Manufacturers Association.
TAIEX-REGIO Workshop on Applying the Partnership Principle in the European Structural and Investment Funds Bratislava, 20/05/2016 Involvement of Partners.
REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.
Protection, Promotion, Development and Management of Indigenous Knowledge Systems Bill [Bill 6—2016] Prof M. Roy Jobson Parliamentary Portfolio Committee.
Regulatory Updates Health Sciences Authority Singapore
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
Submission to The Portfolio Committee of Trade and Industry
PRESENTATION BY CONSUMER GOODS COUNCIL OF SOUTH AFRICA ON:
Grade A Dairy Equivalence
National Department of Health
Karen Proud, President Consumer Health Products Canada
PRESENTATION BY THE LOA TO THE PORTFOLIO COMMITTEE ON FINANCE
THE SELF MEDICATION MANUFACTURERS ASSOCIATION OF SOUTH AFRICA (SMASA)
Proposal for a Regulation on medical devices and Proposal for a Regulation on in vitro diagnostic medical devices Key Provisions and GIRP Assessment.
Regional Seminar for OIE National Focal Points on Animal Production Food Safety Importance of collaboration between the Veterinary Services and industry.
FOODstars Fortified Foods
LEGAL REQUIREMENTS FOR ACT 13 OF 2006
Medicines and Related Substances Amendment Bill RETAILERS’ ASSOCIATION Health Portfolio Committee, 6 August 2008.
Amendments to the Liquor Bill, 2003
DR. P. VINCENT HEGARTY MICHIGAN STATE UNIVERSITY
Amendments to the Liquor Bill, 2003
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
Presentation transcript:

CGCSA Legal & Regulatory Affairs 1 PRESENTATION BY CONSUMER GOODS COUNCIL OF SOUTH AFRICA ON: Proposed Medicines and Related Substances Amendment Bill 2008 Presented by: Nick Tselentis Nigel Sunley

CGCSA Legal & Regulatory Affairs 2 POINTS TO BE RAISED Introduction Impact of the Bill Matters of concern to CGCSA members Need for control over health claims in food Potential interface between FC&D / Medicines & Related Substances Act Some implications Global considerations Summary

CGCSA Legal & Regulatory Affairs 3 CONSUMER GOODS COUNCIL OF SOUTH AFRICA (CGCSA) Is the representative body in South Africa for both manufacturers and retailers of fast moving consumer goods such as food, cleaning materials and toiletries Represents its members on non-competitive issues, particularly in regard to legal and regulatory matters Works to improve supply chain efficiencies and acts as a communication body between manufacturers and retailers

CGCSA Legal & Regulatory Affairs 4 FUNDAMENTALS OF THE BILL The CGCSA welcomes the principles behind the Bill and in particular any aspects of it that improve delivery of effective health services to the public We in principle support the establishment of the South African Health Products Regulatory Authority, provided it results in more effectively managed regulatory processes We do however have considerable concerns regarding the wide ranging nature of the product categories that will potentially be regulated under the Bill and in particular the potential impact on food products

CGCSA Legal & Regulatory Affairs 5 HISTORICAL CONSIDERATIONS The food industry is concerned that the provisions of the proposed Bill in regard to foodstuffs are virtually identical to proposals put forward in 2004 under Act 101 At the time, the food industry and certain scientific bodies (ADSA / NSSA / SAAFoST) put forward comprehensive motivation to the MCC in regard to the exclusion of foodstuffs from Act 101 It appears that these representations have been entirely ignored and no consultation on them has been undertaken by the Department of Health during the interim period We therefore intend to reiterate many of the concerns raised in 2004 as these remain unchanged

CGCSA Legal & Regulatory Affairs 6 IMPACT OF THE BILL ON FOODS CGCSA’s concerns are primarily focussed on the requirement that foodstuffs “making medicinal claims” will fall under the provisions of the Bill We are concerned that no definition is given for “medicinal claim” and that this potentially enables the authorities to arbitrarily place any claim relating to the health and nutrition benefits of a food into this category Such foodstuffs would then be subject to the extremely complex and costly regulations applicable to medicines

CGCSA Legal & Regulatory Affairs 7 THE NEED FOR CONTROL OVER HEALTH CLAIMS The CGCSA fully recognises the need to protect the consumer from inaccurate and misleading statements in regard to the potential health and nutritional benefits of food Such controls are however in place under the Labelling and Advertising Regulations of the Foodstuffs Cosmetics and Disinfectants (FC&D) Act Regulation R642 gazetted for comment in July 2007 specifically incorporates provisions in this area There is no cross-referencing between the Medicines & Related Substances Act and the FC&D Act This has resulted in duplication of regulatory proposals and considerable frustration for the food industry

CGCSA Legal & Regulatory Affairs 8 WE PROPOSE A CLEAR DIFFERENTIATION BETWEEN FOOD AND MEDICINE A food should be regarded as a product that is primarily consumed for the purposes of satisfying hunger and providing essential nutrients Products that provide a preventative health or nutritional benefit as a secondary attribute in addition to meeting the above criteria should also be regarded as foods These products should be regulated solely under the Foodstuffs Cosmetics and Disinfectants Act and adequate substantiation of any claims should be required.

CGCSA Legal & Regulatory Affairs 9 MEDICINES Medicines should continue to be defined as per the Medicines Act i.e. “Any substance or mixture of substances in the use or proportion to be suitable for use or manufacture or sale for use in (a) the diagnosis, treatment, mitigation, modification or prevention of disease, abnormal physical or mental state or the symptoms thereof in man; or (b) restoring, correcting or modifying any somatic or psychic or organic function in man, and includes any veterinary medicine”. Foods should not fall into this category!

CGCSA Legal & Regulatory Affairs 10 HOW TO MANAGE HEALTH AND NUTRITION CLAIMS FOR FOODS? The FC&D Act (both current and proposed amendments) incorporates comprehensive provisions for regulation of claims FC&D Act specifically prohibits the words “heal” and “cure” or “…any other medicinal therapeutic or prophylactic claim.” Proposed amendments gazetted in 2007 make provision for preventative health and nutrition claims: –Nutrient content claims –Enhanced nutrient function claims –Reduction of disease risk claims –Other specific claims e.g. probiotics, glycaemic index, slimming foods Proposed amendments also set out detailed labelling requirements for any food making claims

CGCSA Legal & Regulatory Affairs 11 SOME LIMITED INTERFACE BETWEEN REGULATORY PROCESSES FOR FOODS AND MEDICINES MAY BE DESIRABLE Amendments to FC&D Act propose that the verification process for any new health claims will require a formal protocol Desirable that some measure of standardisation of documentation and process be achieved between foods and medicines - a single body could administer these However specific procedures will be required for foods and the assessing body should comprise food scientists and nutritionists as well as medical practitioners

CGCSA Legal & Regulatory Affairs 12 WHAT WOULD THE IMPLICATIONS BE FOR FOODS IF THE BILL WAS PASSED IN ITS PRESENT FORM? Large numbers of existing foods for which established and well substantiated claims are being made would have to register under the Medicines & Related Substances Act and comply with its provisions in the areas of: –manufacturing procedures –documentation –distribution & warehousing –selling practices, –promotional activities Cost of this would be huge and would probably result in many of them being discontinued The SA consumer would lose the benefits gained from these products or have to pay much more for the products concerned SAHPRA will need further specialist resources for foods – 482 is not enough !

CGCSA Legal & Regulatory Affairs 13 POTENTIAL SCENARIOS Products such as maize meal, yogurt, margarine, certain breakfast cereals and fortified beverages would be treated as medicines as they all contain nutrients and other substances that help to maintain health and make claims for them Manufacturers of these products would have to upgrade their factories to pharmaceutical standards and maintain pharmaceutical-type records Promotion and sampling of these products would be prohibited Rebates and incentives for these products would be prohibited Supermarkets would have to register as pharmacies! WE BELIEVE THESE ARE UNINTENDED CONSEQUENCES OF THE BILL AND REQUEST THAT IT BE RE-CONSIDERED

CGCSA Legal & Regulatory Affairs 14 THE GLOBAL POSITION No country in the world has implemented or is proposing to implement laws that classify foods as medicines Codex Alimentarius (the global food regulatory body) has clear provisions for foods that make health claims and treats them differently from medicines Imported foods will be unable to comply with the Bill, which could then be challenged as a potential Technical Barrier to Trade

CGCSA Legal & Regulatory Affairs 15 IN SUMMARY The Bill has caused huge uncertainty in the food, beverage and retail industries due to lack of clarity and adequate definitions No guidelines in regard to foods were provided, whereas the FC&D Act makes comprehensive provision for regulating claims for foods and provides more than adequate protection to consumers The CGCSA therefore requests that all references to “foodstuffs” in the proposed Bill be removed and that any health and nutrition claims for foods continue to be managed under the Foodstuffs Cosmetics and Disinfectants Act by the Directorate of Food Control Some standardisation of the administrative procedures for approval of new claims for medicines and foodstuffs is however possible and we would encourage our members to support this

CGCSA Legal & Regulatory Affairs 16 THANK YOU Questions are welcomed